BLRX - BioLine Rx Ltd

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5118.99M
Enterprise Value 356.74M
Trailing P/E -4.13
Forward P/E 1-57.00
PEG Ratio (5 yr expected) 10.19
Price/Sales (ttm)N/A
Price/Book (mrq)1.90
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.00

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 0.00%
Operating Margin (ttm)0.00%
Management Effectiveness
Return on Assets (ttm)-22.26%
Return on Equity (ttm)-36.74%
Income Statement
Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.91M
Net Income Avi to Common (ttm)-18.37M
Diluted EPS (ttm)-0.28
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)52.56M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)296k
Total Debt/Equity (mrq)0.51
Current Ratio (mrq)9.91
Book Value Per Share (mrq)0.60
Cash Flow Statement
Operating Cash Flow (ttm)-15.07M
Levered Free Cash Flow (ttm)-11.56M

Trading Information

Stock Price History
Beta 0.01
52-Week Change 310.29%
S&P500 52-Week Change 319.09%
52 Week High 31.38
52 Week Low 30.80
50-Day Moving Average 31.13
200-Day Moving Average 30.97
Share Statistics
Avg Vol (3 month) 3549.47k
Avg Vol (10 day) 3395.02k
Shares Outstanding 5N/A
Float 57.45M
% Held by Insiders 14.80%
% Held by Institutions 141.19%
Shares Short 3537.79k
Short Ratio 30.72
Short % of Float 30.00%
Shares Short (prior month) 3386.54k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A